Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five brokerages that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, one has issued a buy recommendation and one has issued a strong buy recommendation on the company.
Several research firms have recently commented on STVN. Wall Street Zen raised Stevanato Group from a “hold” rating to a “buy” rating in a research report on Friday. Weiss Ratings reiterated a “hold (c)” rating on shares of Stevanato Group in a research note on Monday, December 29th. Finally, Morgan Stanley started coverage on shares of Stevanato Group in a research report on Monday, December 1st. They set an “equal weight” rating and a $24.00 price target for the company.
Institutional Investors Weigh In On Stevanato Group
Stevanato Group Stock Performance
Shares of NYSE:STVN opened at €17.20 on Friday. The firm has a 50 day moving average of €21.06 and a 200 day moving average of €23.41. The company has a quick ratio of 1.30, a current ratio of 1.89 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $5.21 billion, a price-to-earnings ratio of 30.17, a price-to-earnings-growth ratio of 1.42 and a beta of 0.58. Stevanato Group has a 52 week low of €16.30 and a 52 week high of €28.00.
Stevanato Group Company Profile
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Further Reading
- Five stocks we like better than Stevanato Group
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
